Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing 
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch 
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety 
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026 
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement 
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026 
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics 
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round 
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power 
Grok AI Faces Global Scrutiny Over Safeguard Failures and Illegal Content on X 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration 
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure 
GREAT NECK, N.Y., Oct. 23, 2017 -- Manhattan Bridge Capital, Inc. (NASDAQ:LOAN) announced today that its board of directors has authorized a quarterly dividend of $0.11 per share to be paid to all shareholders of record on December 29, 2017. The dividend will be paid on January 15, 2018.
Contact:
Assaf Ran, CEO
(516) 444-3400
